Skip to main content

Table 1 Characteristics of the 108 patients with non-small-cell lung cancer enrolled in the study

From: Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy

  Patients
  N %
Age, Years   
   Median 63
   Range 29 - 77
Gender   
   Male 66 61.1
   Female 42 38.9
Stage   
   IIIA 6 5.5
   IIIB 30 27.8
   IV 72 66.7
PS   
   0 23 21.3
   1 85 78.7
Chemotherapy regimen   
   CBDCA+PAC 89 82.4
   CBDCA+GEM 17 15.7
   CDDP+GEM 2 1.9
Definitive thoracic radiotherapy   
   Yes 20 18.5
   No 88 81.5
  1. Abbreviations: CBDCA, carboplatin; PAC, paclitaxel; CDDP, cisplatin; GEM, gemcitabine